For: | Andersen NN, Jess T. Risk of cardiovascular disease in inflammatory bowel disease. World J Gastrointest Pathophysiol 2014; 5(3): 359-365 [PMID: 25133036 DOI: 10.4291/wjgp.v5.i3.359] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v5/i3/359.htm |
Number | Citing Articles |
1 |
Piero Marin Zivkovic, Andrija Matetic, Ivana Tadin Hadjina, Doris Rusic, Marino Vilovic, Daniela Supe-Domic, Josip Andelo Borovac, Ivana Mudnic, Ante Tonkic, Josko Bozic. Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 2020; 9(3): 628 doi: 10.3390/jcm9030628
|
2 |
Emilio Canovai, Laurens J. Ceulemans, Guido Peers, Lutgart De Pourcq, Marleen Pijpops, Gert De Hertogh, Martin Hiele, Jacques Pirenne, Tim Vanuytsel. Cost analysis of chronic intestinal failure. Clinical Nutrition 2019; 38(4): 1729 doi: 10.1016/j.clnu.2018.07.032
|
3 |
Ge Zhang, He Chen, Yifan Guo, Wei Zhang, Qiuyu Jiang, Si Zhang, Liping Han, She Chen, Ruyi Xue. Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.705325
|
4 |
Bruno G. Loos, Wijnand J. Teeuw, Elena A. Nicu. Oral Infections and General Health. 2016; : 19 doi: 10.1007/978-3-319-25091-5_3
|
5 |
Paul Welsh, Gianluca Grassia, Shani Botha, Naveed Sattar, Pasquale Maffia. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?. British Journal of Pharmacology 2017; 174(22): 3898 doi: 10.1111/bph.13818
|
6 |
Guo-Cui Wu, Rui-Xue Leng, Qi Lu, Yin-Guang Fan, De-Guang Wang, Dong-Qing Ye. Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Angiology 2017; 68(5): 447 doi: 10.1177/0003319716652031
|
7 |
Özge Uluçkan, Erwin F. Wagner. Chronic systemic inflammation originating from epithelial tissues. The FEBS Journal 2017; 284(4): 505 doi: 10.1111/febs.13904
|
8 |
Arkadiusz Michalak, Paula Mosińska, Jakub Fichna. Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives. Pharmacological Reports 2016; 68(4): 837 doi: 10.1016/j.pharep.2016.04.016
|
9 |
Wenjie Ma, Yanping Li, Yoriko Heianza, Kyle D. Staller, Andrew T. Chan, Eric B. Rimm, Kathryn M. Rexrode, Lu Qi. Associations of Bowel Movement Frequency with Risk of Cardiovascular Disease and Mortality among US Women. Scientific Reports 2016; 6(1) doi: 10.1038/srep33005
|
10 |
Valeriy N. Marchenko, Oksana B. Shchukina, Denis A. Davydov, Anastasiya I. Bogacheva, Veniamin V. Banko, Alexandra R. Makarenko. Endothelial dysfunction in axial spondyloarthritis associated with inflammatory bowel disease. HERALD of North-Western State Medical University named after I.I. Mechnikov 2023; 14(4): 17 doi: 10.17816/mechnikov108408
|
11 |
Cristian Scheau, Constantin Caruntu, Ioana Anca Badarau, Andreea-Elena Scheau, Anca Oana Docea, Daniela Calina, Ana Caruntu. Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier. Journal of Personalized Medicine 2021; 11(6): 494 doi: 10.3390/jpm11060494
|
12 |
Benoit Follin-Arbelet, Milada Cvancarova Småstuen, Øistein Hovde, Lars-Petter Jelsness-Jørgensen, Bjørn Moum. Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study). Journal of Crohn's and Colitis 2023; 17(4): 497 doi: 10.1093/ecco-jcc/jjac156
|
13 |
Anders Boeck Jensen, Teresa Adeltoft Ajslev, Søren Brunak, Thorkild I A Sørensen. Long-term risk of cardiovascular and cerebrovascular disease after removal of the colonic microbiota by colectomy: a cohort study based on the Danish National Patient Register from 1996 to 2014. BMJ Open 2015; 5(12): e008702 doi: 10.1136/bmjopen-2015-008702
|
14 |
Matthew Stephens, Pierre-Yves von der Weid. Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner. Gut Microbes 2020; 11(3): 421 doi: 10.1080/19490976.2019.1629235
|
15 |
João Lucas Penteado Gomes, Tiago Fernandes, Ursula Paula Reno Soci, André Casanova Silveira, Diego Lopes Mendes Barretti, Carlos Eduardo Negrão, Edilamar Menezes Oliveira, Ryuichi Morishita. Obesity Downregulates MicroRNA‐126 Inducing Capillary Rarefaction in Skeletal Muscle: Effects of Aerobic Exercise Training. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/2415246
|
16 |
Thomas Sharpton, Svetlana Lyalina, Julie Luong, Joey Pham, Emily M. Deal, Courtney Armour, Christopher Gaulke, Shomyseh Sanjabi, Katherine S. Pollard, Jack A. Gilbert. Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice. mSystems 2017; 2(5) doi: 10.1128/mSystems.00036-17
|
17 |
Kenneth M. Borow, R. Preston Mason, Krishnaswami Vijayaraghavan. Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review. Cardiorenal Medicine 2018; 8(1): 18 doi: 10.1159/000479391
|
18 |
Shashi Kiran, Sunil Sapkota, Prashanth Shetty, ThittamaranahalliMuguregowda Honnegowda. Effect of yogic colon cleansing (laghu sankhaprakshalana kriya) on bowel health in normal individuals. Yoga Mimamsa 2019; 51(1): 26 doi: 10.4103/ym.ym_4_19
|
19 |
Carlos G. Santos-Gallego, Maria Wallert, Karlheinz Peter. Myocardial infarction caused by surgery: Blame inflammation not the surgeon. Atherosclerosis 2016; 255: 113 doi: 10.1016/j.atherosclerosis.2016.08.044
|
20 |
Soonjae Hwang, Chan Oh Park, Ki-Jong Rhee. Targeting the Gut Microbiome to Ameliorate Cardiovascular Diseases. Biomedical Science Letters 2017; 23(3): 166 doi: 10.15616/BSL.2017.23.3.166
|
21 |
Matthew G. Nevulis, Colby Baker, Edward Lebovics, William H. Frishman. Overview of Link Between Inflammatory Bowel Disease and Cardiovascular Disease. Cardiology in Review 2018; 26(6): 287 doi: 10.1097/CRD.0000000000000214
|